General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Mitsubish Tanabe(MODEST), Silence Therapeutics(MODEST), Silence Therapeutics(MODEST) SPEAKER'S BUREAU: Amarin(MODEST), Amarin(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Caristo Diagnostics(SIGNIFICANT), Caristo Diagnostics(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Sanofi(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT)

View Full Disclosure